1. 301 Metabolic syndrome and coronary heart disease
- Author
-
Faouzi Maatouk, Hichem Denguir, Sonia Hamdi, Khaldoun Ben Hamda, Khadija Mzoughi, Feriel Moatemri, and Mohamed Amine Majdoub
- Subjects
medicine.medical_specialty ,education.field_of_study ,Multivariate analysis ,Waist ,business.industry ,Population ,Patient characteristics ,Mean age ,medicine.disease ,Coronary heart disease ,Endocrinology ,Diabetes mellitus ,Internal medicine ,Medicine ,Metabolic syndrome ,Cardiology and Cardiovascular Medicine ,business ,education - Abstract
The value of metabolic syndrome (Mets) in the identification of high cardiovascular risk subjects remains questionable. We sought to examine the association among Mets and the occurrence of a coronary heart disease (CHD). Methods Between 2006 and 2008, 540 patients were screened for the Mets according to the NCEP-ATP III definition. The mean age was 61 ± 12.3 years, 63.3% were men. Mets was diagnosed in 60% of the population. 276 had CHD confirmed by angiocoronarography (51,1%). Results Patients characteristics are presented in the table. CHD(+) (n=276) CHD(-) (n=264) P Age (years) 62 ± 10,2 60 ± 15,2 Men 75,4% 50,8% Smokers 48,9% 24,2% BMI (kg/m2) 28,5 ± 4,6 28,3 ± 6,5 Waist (cm) 100,2 ± 12,6 98 ± 14 0,08 SBP (mmHg) 133 ± 20,2 132 ± 24,2 0,06 Diabetes 52,9% 23,1% Hypertension 52,8% 46% TG (mmol/l) 1,96 ± 1,1 1,63 ± 1 HDLc (mmol/l) 1,06 ± 0,5 1,2 ± 0,5 CHD (+) patients had a higher prevalence of metabolic syndrome: 74,6% versus 44,7% (p=0.05). Multivariate analyses revealed that only Mets was significantly associated with CHD (OR: 1.48 95% CI: 1.10-2.4, p=0.05). Conclusion Our study indicates that MetS is highly prevalent and that it seems to be correlated to CHD.
- Full Text
- View/download PDF